Para fornecer o conteúdo mais relevante aos leitores do HealthCare Business News, pedimos que você compartilhe um pouco de informação sobre quem você é (leva dois segundos e pronto).
GE HealthCare has announced that it will acquire MIM Software, giving it access to the company’s imaging analytics and workflow software with advanced digital capabilities that it will use to improve imaging and care coordination for treating multiple diseases.
Used by imaging centers and hospitals worldwide for radiation oncology, molecular radiotherapy, diagnostic imaging, and urology, MIM’s vendor-agnostic software integrates diagnostic images from multiple modalities into treatment plans. With it, clinicians can reduce repetitive tasks and manual interventions via automation; add quantitation and advanced processing to diagnostic imaging and nuclear medicine to evaluate patient responses to treatments; and have a platform to assist with theranostics imaging and dosimetry.
With new therapies being released, providers are looking to integrate more advanced imaging devices and digital-based solutions that will allow them to access information faster and produce more effective treatment plans. As part of its precision care strategy, GE HealthCare plans to integrate MIM Software’s technology with its advanced visualization solutions to add AI-based segmentation and contouring, as well as dosimetry analysis to make clinicians better able to precisely evaluate patients throughout the course of their treatment.
"GE HealthCare is committed to developing smart, AI-powered devices that cater to specific disease states, thereby enabling clinicians to deliver more personalized care. We expect the integration of MIM Software will also advance our efforts in connecting data across care pathways,” said Dr. Taha Kass-Hout, chief technology officer of GE HealthCare, in a statement.
Looking to add these capabilities primarily in radiology, molecular imaging, and radiation oncology, specific examples of what GE HealthCare will do with these newfound capabilities include facilitating theranostics in oncology for treating advanced prostate cancer; streamlining workflow solutions in radiation oncology to simplify complex cancer treatment plans; providing beta-amyloid imaging in neurology for diagnosing and monitoring Alzheimer’s; and offering myocardial perfusion to diagnose coronary artery disease.
Founded in 2003, MIM Software is headquartered in Cleveland, and the company has additional offices in China and Belgium.
